During the past decade, Allergy, Asthma and Immunology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy, Asthma and Immunology Associates" are "Seasonal Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Allergy, Asthma and Immunology Associates" in a lesser frequency.

Most popular intervention types in "Allergy, Asthma and Immunology Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "0.1% azelastine hydrochloride 1096 mcg daily" (1 trials), "0.15% azelastine hydrochloride 1644 mcg daily" (1 trials), "azelastine Hcl" (1 trials) and "azelastineHcl / fluticasone propionate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy, Asthma and Immunology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Allergy, Asthma and Immunology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Allergy, Asthma and Immunology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy, Asthma and Immunology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".